Partial Liquid Ventilation does not Affect BALF TNF-α, MIP-2, CINC-1 Concentrations, or CD11b Cell Surface Expression, but does Increase Macrophage Proportion among BALF Cells in the Acute Phase of Rat LPS-Induced Lung Injury

Acta Medica Okayama

Volumn 57, Issue 3, 2003, Pages 133-141

  Komori, Eisaku ^a   Shoga, Kazuhiko ^a   Aoe, Motoi ^a   Sawada, Shigeki ^a   Ichiba, Shingo ^a   Shimizu, Nobuyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Anti inflammatory effect; BAL; Cytokine; Flow cytometry; Partial liquid ventilation

Indexed keywords

CD11B ANTIGEN; CELL SURFACE MARKER; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; PERFLUOROOCTYL BROMIDE; POLYHALO DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LEUKOCYTE; LIQUID VENTILATION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ACUTE-PHASE REACTION; ANIMALS; ANTIGENS, CD11B; BRONCHOALVEOLAR LAVAGE FLUID; CELL MEMBRANE; CHEMOKINES, CXC; FLOW CYTOMETRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; LIQUID VENTILATION; LUNG DISEASES; MACROPHAGES; MALE; OSMOLAR CONCENTRATION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0242573197     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, DeLemos R and Fuhrman BP: The LiquiVent Study Group: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med (1996) 335: 761-767.
2. Curtis SE, Peek JT and Kelly DR: Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol (1993) 75: 2696-2702.
3. Hirschl RB, Tooley R, Parent AC, Johnson K and Bartlett RH: Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation. A study model in a setting of severe respiratory failure. Chest (1995) 108: 500-508.
4. Overbeck MC, Pranikoff T, Yadao CM and Hirschl RB: Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure. Crit Care Med (1996) 24: 1208-1214.
5. Sawada S, Ichiba S, Itano H, Shoga K and Shimizu N: Experimental study of partial liquid ventilation in the setting of acute respiratory failure induced by sea water lung lavage in rabbits. Acta Med Okayama (1998) 52: 131-137.
6. Al-Rahmani A, Awad K, Miller TF, Wolfson MR and Shaffer TH: Effects of partial liquid ventilation with perfluorodecalin in the juvenile rabbit lung after saline injury. Crit Care Med (2000) 28: 1459-1464.
7. Hirschl RB, Pranikoff T, Gauger P, Schreiner RJ, Dechert R and Bartlett RH: Liquid ventilation in adults, children, and full-term neonates. Lancet (1995) 346: 1201-1202.
8. Hirschl RB, Pranikoff T, Wise C, Overbeck MC, Gauger P, Schreiner RJ, Dechert R and Bartlett RH: Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA (1996) 275: 383-389.
9. Gauger PG, Pranikoff T, Schreiner RJ, Moler FW and Hirschl RB: Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med (1996) 24: 16-22.
10. Pranikoff T, Gauger PG and Hirschl RB: Partial liquid ventilation in a child on extracorporeal life support. ASAIO J (1996) 42: 317-320.
11. Pranikoff T, Gauger PG and Hirschl RB: Partial liquid ventilation in newborn patients with congenital diaphragmatic hernia. J Pediatr Surg (1996) 31: 613-618.
12. Greenspan JS, Fox WW, Rubenstein SD, Wolfson MR, Spinner SS and Shaffer TH: Partial liquid ventilation in critically ill infants receiving extracorporeal life support. Philadelphia Liquid Ventilation Consortium. Pediatrics (1997) 99: E2.
13. Greenspan JS, Wolfson MR and Shaffer TH: Liquid ventilation: Clinical experiences. Biomed Instrum Technol (1999) 33: 253-259.
14. Smith TM, Steinhorn DM, Thusu K, Fuhrman BP and Dandona P: A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med (1995) 23: 1533-1539.
15. Thomassen MJ, Buhrow LT and Wiedemann HP: Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med (1997) 25: 2045-2047.
16. Rossman JE, Caty MG, Rich GA, Karamanoukian HL and Azizkhan RG: Neutrophil activation and chemotaxis after in vitro treatment with perfluorocarbon. J Pediatr Surg (1996) 31: 1147-1150.
17. Kramer BW, Ikegami M and Jobe AH: Intratracheal endotoxin causes systemic inflammation in ventilated preterm lambs. Am J Respir Crit Care Med (2002) 165: 463-469.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 72: 248-254.
19. Nakagawa H, Komorita N, Shibata F, Ikesue A, Konishi K, Fujioka M, and Kato H: Identification of cytokine-induced neutrophil chemoattractants (CINC), rat GRO/CINC-2 alpha and CINC-2 beta, produced by granulation tissue in culture: Purification, complete amino acid sequences and characterization. Biochem J (1994) 301: 545-550.
20. Czermak BJ, Sarma V, Bless NM, Schmal H, Friedl HP and Ward PA: In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. J Immunol (1999) 162: 2321-2325.
21. Shibata F, Kato H, Konishi K, Okumura A, Ochiai H, Nakajima K, Al-Mokdad M and Nakagawa H: Differential changes in the concentrations of cytokine-induced neutrophil chemoattractant (CINC)-1 and CINC-2 in exudate during rat lipopolysaccharide-induced inflammation. Cytokine (1996) 8: 222-226.
22. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP and Ward PA: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol (1997) 158: 3439-3448.
23. Bless NM, Warner RL, Padgaonkar VA, Lentsch AB, Czermak BJ, Schmal H, Friedl HP and Ward PA: Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am J Physiol (1999) 276: L57-63.
24. Rotta AT and Steinhorn DM: Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. Crit Care Med (1998) 26: 1707-1715.
25. Colton DM, Till GO, Johnson KJ, Dean SB, Bartlett RH and Hirschl RB: Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med (1998) 26: 1716-1724.
26. Nader ND, Knight PR, Davidson BA, Safaee SS and Steinhorn DM: Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats. Anesth Analg (2000) 90: 356-361.
27. Younger JG, Taqi AS, Till GO and Hirschl RB: Partial liquid ventilation protects lung during resuscitation from shock. J Appl Physiol (1997) 83: 1666-1670.
28. Itano H, Aoe M, Ichiba S, Yamashita M, Date H, Andou A and Shimizu N: Partial liquid ventilation for acute allograft dysfunction after canine lung transplantation. Ann Thorac Surg (1999) 67: 332-339.
29. Lange NR, Kozlowski JK, Gust R, Shapiro SD and Schuster DP: Effect of partial liquid ventilation on pulmonary vascular permeability and edema after experimental acute lung injury. Am J Respir Crit Care Med (2000) 162: 271-277.
30. Weiss DJ, Bonneau L and Liggitt D: Use of perfluorochemical liquid allows earlier detection of gene expression and use of less vector in normal lung and enhances gene expression in acutely injured lung. Mol Ther (2001) 3: 734-745.
31. van Eeden SF, Klut ME, Leal MA, Alexander J, Zonis Z and Skippen P: Partial liquid ventilation with perfluorocarbon in acute lung injury: Light and transmission electron microscopy studies. Am J Respir Cell Mol Biol (2000) 22: 441-450.
32. Martin TR: Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol (2000) 23: 128-132.
33. Baba A, Kim YK, Zhang H, Liu M and Slutsky AS: Perfluorocarbon blocks tumor necrosis factor-alpha-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med (2000) 28: 1113-1118.
34. Varani J, Hirschl RB, Dame M and Johnson K: Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock (1996) 6: 339-344.